5-Hydroxytryptamine Receptor 2B (HTR2B) Antibody

Este producto es parte de HTR - 5-Hydroxytryptamine receptors
Product Graph
312€ (60 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
5-Hydroxytryptamine Receptor 2B (HTR2B) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx006284
tested applications
WB

Description

HTR2B Antibody is a Rabbit Polyclonal Antibody against HTR2B.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
5-Hydroxytryptamine Receptor 2B (HTR2B)
Host
Rabbit
Reactivity
Human, Mouse
Recommended Dilution
WB: 1/200 - 1/1000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified by affinity chromatography.
Size 1
60 µl
Size 2
120 µl
Size 3
200 µl
Form
Liquid
Tested Applications
WB
Buffer
PBS, pH 7.3, containing 0.02% sodium azide, 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P22492
Gene ID
3357
NCBI Accession
NP_000858.3
Alias
HTR2B,5-HT2B, 5-HT-2B, 5-HT(2B),5-HT2B receptor
Background
Antibody anti-HTR2B
Status
RUO
Note
Concentration: 1 mg/ml - 

Descripción

HTR2B is another subtype of the G protein-coupled serotonin receptors that modulates diverse physiological functions, including cardiovascular function, smooth muscle contraction, and mood regulation. HTR2B is expressed in the central nervous system (CNS) and peripheral tissues, particularly in the heart, liver, and gastrointestinal tract. In the CNS, it plays a role in mood stabilization and reward processing by regulating the release of neurotransmitters like dopamine. HTR2B is also critical for the development and maintenance of cardiac function, as its activation leads to cardiac hypertrophy and structural remodeling. Dysregulation of HTR2B has been linked to pulmonary hypertension, where its overactivation promotes abnormal vasoconstriction and vascular remodeling. It is also implicated in drug-induced valvular heart disease, particularly from medications like fenfluramine and MDMA (ecstasy), which act as HTR2B agonists. HTR2B’s interaction with serotonergic pathways suggests its relevance in mood disorders, impulsivity, and addiction. Genetic variants in HTR2B have been associated with behavioral abnormalities, such as aggressive impulsivity. Although less studied compared to HTR2A, HTR2B is increasingly recognized as a therapeutic target for cardiovascular disorders, mood stabilization, and conditions involving abnormal serotonin signaling, such as valvular diseases and pulmonary vascular conditions.

Related Products

abx004337

5-Hydroxytryptamine Receptor 2B (HTR2B) Antibody

HTR2B Antibody is a Rabbit Polyclonal antibody against HTR2B. This gene encodes one of the several different receptors for 5-hydroxytryptamine (serotonin) that belongs to the G-protein coupled receptor 1 family. Serotonin is a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. Serotonin receptors mediate many of the central and peripheral physiologic functions of serotonin, including regulation of cardiovascular functions and impulsive behavior. Population and family-based analyses of a minor allele (glutamine-to-stop substitution, designated Q20*) which blocks expression of this protein, and knockout studies in mice, suggest a role for this gene in impulsivity. However, other factors, such as elevated testosterone levels, may also be involved.

Ver Producto
abx006284

5-Hydroxytryptamine Receptor 2B (HTR2B) Antibody

HTR2B Antibody is a Rabbit Polyclonal Antibody against HTR2B.

Ver Producto
abx026102

5-Hydroxytryptamine Receptor 2B (HTR2B) Antibody

Multiple receptor subtypes of serotonin neurotransmitters with multiple physiologic functions have been recognized. The 5-HT-2 receptors mediate many of the central and peripheral physiologic functions of serotonin. Cardiovascular effects include contraction of blood vessels and shape changes in platelets; central nervous system effects include neuronal sensitization to tactile stimuli and mediation of hallucinogenic effects of phenylisopropylamine hallucinogens.

Ver Producto